StockVS

American Well Corporation (AMWL) Stock Analysis

Healthcare

American Well Corporation

$8.48

+$0.52 (+6.53%)

Last Updated: May 26, 2026

Price History

Analysis

Company Overview

American Well Corporation operates as an enterprise platform and software company that delivers digitally enabling hybrid care solutions across the United States and internationally. The organization functions within the healthcare sector, specifically focusing on the health information services industry, which implies a reliance on technology infrastructure to support clinical operations and data management across various care settings. The company's current market capitalization stands at $87.39M, with reported annual revenue of $249.32M and an employee count of 562 individuals. These valuation and revenue figures indicate that the company maintains a relatively small market footprint compared to large-cap healthcare peers, suggesting it operates as a specialized player rather than a dominant market leader in its niche.

Financial Health

The company reported a revenue of $249.32M over the trailing twelve months, while posting a net income of $-95,700,000 and an EBITDA of $-60,111,000. The substantial gap between the positive revenue figure and the significant negative net income reveals a cost structure where operating expenses, likely driven by research, development, or sales efforts, are consuming more than 38% of total revenue. Free cash flow stands at $-12,869,375, indicating that the company is currently burning cash, which limits its immediate financial flexibility for internal expansion or acquisitions without external capital injection. Analyzing the margins, the gross margin is 53.8%, suggesting reasonable efficiency in core service delivery, whereas the operating margin of -25.2% and profit margin of -38.4% highlight significant overhead burdens eroding profitability. The balance sheet shows $182.33M in cash against $4.52M in debt, resulting in a debt-to-equity ratio of 1.83, which suggests a leveraged position despite the substantial cash reserve. The current ratio is 3.37, indicating a strong liquidity position with current assets significantly exceeding current liabilities. Furthermore, the return on equity is -33.7% and the return on assets is -15.5%, revealing that management effectiveness in generating returns on invested capital is currently negative due to the ongoing losses.

Valuation Assessment

The trailing P/E ratio is listed as N/A due to the lack of earnings, while the forward P/E is -2.67, a negative metric that implies the market does not expect near-term earnings growth sufficient to justify a traditional multiple. The price-to-book ratio is 0.37, indicating that the stock trades at a significant discount to its book value, which often reflects market skepticism regarding the quality of assets or the ability to generate future profits. Alternative valuation metrics such as the price-to-sales ratio of 0.35 and an EV/EBITDA of 1.30 suggest the market is pricing the company based on revenue generation rather than profitability, as negative earnings render standard earnings-based multiples less relevant. The 52-week high is $9.15 and the 52-week low is $3.71; without a specific current price provided in the facts, the range defines the volatility corridor, but the negative forward P/E suggests the current price is likely positioned below the historical high given the financial constraints. The beta value is 1.43, which means the stock is expected to be 43% more volatile than the broader market, exposing investors to higher price swings during periods of market turbulence.

Growth & Income

The revenue growth year-over-year is -22.1%, while earnings growth is N/A, indicating that the company is currently contracting in terms of top-line sales rather than expanding. Since earnings are negative, there is no earnings growth to compare against revenue, but the negative revenue growth implies a challenging market environment or a decline in customer demand that is outpacing any potential cost-cutting measures. The company does not pay a dividend, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which confirms that all available earnings are theoretically available for reinvestment, though currently absorbed by losses. Consequently, the overall growth and income profile is characterized by negative revenue momentum and a complete absence of income distribution to shareholders, relying entirely on potential future operational turnaround to restore positive growth trajectories.

Peer Comparison

American Well Corporation (AMWL) operates in the Health Information Services industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
American Well Corporation AMWL $141.69M N/A
Veeva Systems Inc. VEEV $25.87B 29.1
BrightSpring Health Services, Inc. BTSG $11.70B 78.3
Tempus AI, Inc. TEM $8.38B N/A

The Health Information Services industry average P/E ratio is 57.5x. American Well Corporation trades at a P/E of N/A.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About American Well Corporation

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care. It also provides specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members; Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Visit website →

Key Statistics

Market Cap
$141.69M
P/E Ratio
N/A
52-Week High
$9.15
52-Week Low
$3.71
Avg Volume
61.08K
Beta
1.53

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NYSE
Country
United States
Employees
562